• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Small Innovators & Niche CROs

    Focus on Science

    Rapid and Data Rich Chromatographic Method Development

    Preparing Your Post Pandemic Talent Strategy

    How Modern Near-Infrared Came to Be
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Nanoform, Aprecia Partner to Advance 3DP Nanomedicines

    KemPharm Receives $10M Milestone for FDA Approval of Azstarys

    Valneva Focuses on Bilateral Discussions to Supply COVID-19 Vax

    Syneos, Medable Partner for New Decentralized Capabilities

    CSafe Global Appoints SVP of Technology and Innovation
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Evotec to Build Second Biologics Mfg. Facility in Toulouse

    Abenza Chooses North Carolina for New Biologics Manufacturing Site

    Catalent Adds Cryogenic Capabilities at Philadelphia Facility

    Recro, Ensysce Expand Development and Manufacturing Partnership

    Metrics Names Stephanie Emory Associate Director of Pharma Development
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    TraceLink Introduces Opus Platform

    Obituary Notice: Russell “Russ” Haines

    Catalent Adds Cryogenic Capabilities at Philadelphia Facility

    Cryoport Acquires Critical Transport Solutions Australia

    PharmParts – This Makes Sense!
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Nanoform, Aprecia Partner to Advance 3DP Nanomedicines

    KemPharm Receives $10M Milestone for FDA Approval of Azstarys

    Valneva Focuses on Bilateral Discussions to Supply COVID-19 Vax

    Syneos, Medable Partner for New Decentralized Capabilities

    Valneva’s Inactivated, Adjuvanted COVID-19 Vax Achieves Positive Data
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Unifying Quality Manufacturing to Drive Speed, Collaboration, and Compliance

    Ensuring Pharma Manufacturing Quality

    What Will Change at FDA for 2021?

    RBQM Comes of Age: COVID as a Catalyst for Change

    Post-Pandemic Regulations
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Aphena Pharma Solutions

    Adare Pharma Solutions

    Reed-Lane

    Syngene

    Baxter BioPharma Solutions
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Reed-Lane

    Adare Pharma Solutions

    Almac Group

    Aphena Pharma Solutions

    Quotient Sciences
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Expert's Opinion

    Rising to The Occasion: The High Stakes of Vaccine Transport

    How logistical precision can ensure safe and efficient delivery of the COVID-19 vaccine.

    Rising to The Occasion: The High Stakes of Vaccine Transport
    Related CONTENT
    • TraceLink Introduces Opus Platform
    • Johnson & Johnson 1Q Results
    • RDIF, Hualan Ink COVID-19 Vaccine Deal
    • Pfizer, BioNTech Expand COVID-19 Vaccine Agreement with EU
    • Evotec Enters Master Service Agreement with Kazia Therapeutics
    Bill Brooks, Vice President of North America Transportation Portfolio at Capgemini11.04.20

    As the current health crisis persists, many are eagerly anticipating the release of a viable vaccine. Medical professionals and biopharmaceutical companies are working around the clock in order to be ready to safely – and efficiently – deliver vaccines to 300 million Americans next year.

    The U.S. is accustomed to transporting vaccines in large volumes for flu protection. According to the Centers for Disease Control and Prevention (CDC), vaccine manufacturers have projected that they will supply as many as 194 to 198 million doses of influenza vaccine for the 2020-2021 season.

    While that number of vaccinations at scale is impressive in its own right, the COVID-19 vaccine will likely have many differentiators. It may require multiple doses taken in specifically timed increments.  Refrigeration and temperature control conditions will also need to be considered, as storage temperatures for the COVID-19 vaccine are much colder than the average flu vaccine. Health officials will also need to prioritize who gets the vaccine and in what order – and how to simultaneously distribute it across the country. And security concerns will need to be addressed well before the vaccine leaves the manufacturer.

    With so many variables, the transportation strategy must be approached with precision and accuracy. Any small misstep could be the difference between a lost, delayed, or damaged delivery and a successful inoculation. Executing this transportation properly can save lives.

    On the road: what does vaccine transport look like?

    The CDC has carefully developed a precise protocol for storing, handling, and distributing the flu vaccine. Because so much of the COVID-19 vaccine is still largely unknown and undefined, it is difficult to predict how best to prepare the logistics component of travel and delivery.  

    However, by knowing what we know about vaccine transport etiquette and the pharma industry, we can accurately gauge four key considerations that may present challenges when transporting the COVID-19 vaccine:

    1. Timing: There are 100 million Americans at high risk of infection because of their work, age, or health. While there has been a lot of discussion about who will receive the vaccine first, initial supplies look like they will cover only a fraction of the high-priority groups. With that in mind, the vaccine will likely be distributed in four phases. Officials and advisors are also considering how to prioritize people who don’t work in healthcare but have important jobs in food production and supply chain.

    2. Tracking: To ensure the transportation and delivery of vaccines are being executed properly, it is likely that trucks and cargo planes will be tracked. Vaccine manufacturers are turning to GPS software for tracking distribution and plan to employ the use of empty so-called dummy trucks to throw off thieves, according to The Wall Street Journal. Air carriers have begun to prepare for new temperature-monitoring systems to track future vaccine shipments.

    3. Support: While the CDC (Centers for Disease Control and Prevention) will coordinate U.S. vaccine distribution, large shipping and logistics companies will likely be called upon to help. Vaccine makers are already in talks with delivery companies with plans to purchase vast amounts of cargo space in preparation for distribution. Pharmaceutical companies are considering tasking drones to deliver vaccines in remote areas since many rural regions lack adequate infrastructure to support traditional delivery methods.

    4. Security: Shipping companies, distribution centers, and destinations will need to develop new protocol to ensure the vaccines will be protected and secure throughout the entire journey: this includes from the time it leaves the manufacturer to the moment it reaches each person for inoculation. There’s also speculation that U.S. marshals will be sent to accompany shipments of vaccines once they are ready for immediate distribution. Glassmakers are even adding black-light verification to vials so as to curb counterfeiting efforts.

    The future of transportation and logistics

    Due to the scale and scope, it’s clear there are several potential hurdles to consider when transporting the COVID-19 vaccine. While the size of this undertaking is largely unprecedented, it does present several opportunities for business growth and new efficiencies in the transportation and logistics space. PPE manufacturers and pharma companies have recently had a wake-up call to adapt and modernize to the changing times. Now is the time to revisit the tried and true supply chain processes and optimize them for future success.

    With so much on the line, approaching the logistics of vaccine transport with tactical precision is key. Just like when developing the vaccine itself or completing a treatment or procedure – there is no room for error in the delivery and synchronization of transport. Every day, pharma strives for complete focus and accuracy – and each logistical aspect needs to mirror that mindset in order to be successful.

    Related Searches
    • Biologics, Proteins, Vaccines
    Suggested For You
    TraceLink Introduces Opus Platform TraceLink Introduces Opus Platform
    Johnson & Johnson 1Q Results Johnson & Johnson 1Q Results
    RDIF, Hualan Ink COVID-19 Vaccine Deal RDIF, Hualan Ink COVID-19 Vaccine Deal
    Pfizer, BioNTech Expand COVID-19 Vaccine Agreement with EU Pfizer, BioNTech Expand COVID-19 Vaccine Agreement with EU
    Evotec Enters Master Service Agreement with Kazia Therapeutics Evotec Enters Master Service Agreement with Kazia Therapeutics
    Arkema Recruits Dotmatics as its R&D Digitalization Partner Arkema Recruits Dotmatics as its R&D Digitalization Partner
    ATMPS, Ori Biotech Integrate Digital Platform for Cell & Gene Therapies ATMPS, Ori Biotech Integrate Digital Platform for Cell & Gene Therapies
    Executive Moves: Novavax Executive Moves: Novavax
    Ensuring Pharma Manufacturing Quality Ensuring Pharma Manufacturing Quality
    Catalent Biologics Completes Madison Expansion Catalent Biologics Completes Madison Expansion
    Vetter Development Service Vetter Development Service
    Vetter Packaging Solutions Vetter Packaging Solutions
    Merck KGaA Selects PRA’s Remote Patient Monitoring Platform Merck KGaA Selects PRA’s Remote Patient Monitoring Platform
    Agilex Biolabs Acquires TetraQ for APAC Expansion Plans Agilex Biolabs Acquires TetraQ for APAC Expansion Plans
    Kindeva Drug Delivery and Cambridge Healthcare Innovations Collaborate Kindeva Drug Delivery and Cambridge Healthcare Innovations Collaborate

    Related Expert's Opinion

    • Biologics, Proteins, Vaccines | Drug Development
      The Importance of Global Collaboration in the Fight Against COVID-19

      The Importance of Global Collaboration in the Fight Against COVID-19

      Industry continues to join forces to find new treatments for COVID-19.
      Dohyun Cho, Chief Operating Officer, Enzychem Lifesciences 09.08.20

    • Biologics, Proteins, Vaccines | Clinical Trials | Drug Development
      Global Biotech: Leading Health Care Innovation and How CROs Are Adapting to Meet Their Needs

      Global Biotech: Leading Health Care Innovation and How CROs Are Adapting to Meet Their Needs

      New models from CROs are enabling further biotech expansion
      Davide Garrisi, Biotech Portfolio Lead, PPD Biotech 08.20.20

    • Biologics, Proteins, Vaccines | cGMP Manufacture | Drug Development
      Tackling Analytical Challenges in Gene Therapy

      Tackling Analytical Challenges in Gene Therapy

      Key considerations on how to navigate the field as a gene therapy developer.
      Khanh Ngo Courtney, Ph.D., Biologics Project Director, Avomeen 07.17.20


    • Biologics, Proteins, Vaccines | cGMP Manufacture | Logistics | Supply Chain
      New Supply Chain Considerations in Response to COVID-19

      New Supply Chain Considerations in Response to COVID-19

      Cell & gene therapy companies have faced unique challenges due to the nature of their therapies, this is especially true for autologous cell therapies.
      Mark Stielow, Senior Director of Cell Manufacturing & Technical Operations, Adaptimmune 06.10.20

    • Biologics, Proteins, Vaccines | Clinical Trials | Drug Development | Logistics
      The Importance of CAR-T Cell Therapy in Clinical Trials

      The Importance of CAR-T Cell Therapy in Clinical Trials

      The Industry’s Evolving, Maturing Focus
      Panteli Theocharous, Global Vice President, Cell and Gene Therapy Strategy Lead, PPD 05.26.20

    • Biologics, Proteins, Vaccines | Drug Development | Information Technology
      Speeding Vaccine Development with Advanced Analytics

      Speeding Vaccine Development with Advanced Analytics

      Having immediate access to wide ranging resources of data can help speed the COVID-19 vaccine development process
      Dr. Shlomi Madar, VP of Healthcare Solutions, Signals Analytics 04.15.20


    • Biologics, Proteins, Vaccines | cGMP Manufacture | Drug Development | Scale-up/Technology Transfer
      Robust Response to COVID-19 Demand

      Robust Response to COVID-19 Demand

      What it’s going to take to develop, scale-up, and manufacture the products needed to address the COVID-19 outbreak.
      Christa Myers, Pharmaceutical Market Sector Lead, CRB 03.31.20

    • Biologics, Proteins, Vaccines | Drug Development
      Immunogenicity Assessment of Gene Therapy Compounds

      Immunogenicity Assessment of Gene Therapy Compounds

      Dr. Kromminga of BioAgilytix discusses testing challenges and evolving trends in gene therapy.
      Dr. Arno Kromminga, global chief scientific officer, BioAgilytix 11.27.19

    • Biologics, Proteins, Vaccines | Clinical Trials
      Advanced Therapies: Adding a New Layer of Complexity to Clinical Trials

      Advanced Therapies: Adding a New Layer of Complexity to Clinical Trials

      Overcoming the challenges of a new and changing clinical trial landscape
      Erin Finot, Global Head of Immuno-Oncology, IQVIA Biotech 11.18.19


    • Biologics, Proteins, Vaccines | cGMP Manufacture | Clinical Trial Materials | Scale-up/Technology Transfer
      The Pain-Free Guide: Transitioning from Clinical Production to Commercial Manufacturing

      The Pain-Free Guide: Transitioning from Clinical Production to Commercial Manufacturing

      Cell and gene therapy facilities face a unique set of challenges as they scale towards commercial production and require equally unique solutions
      Peter Walters , Lead Process Engineer, CRB USA 11.11.19

    • Biologics, Proteins, Vaccines | cGMP Manufacture | Drug Development
      Continued and Consistent Investment in Manufacturing Facilities

      Continued and Consistent Investment in Manufacturing Facilities

      As companies move their cell and gene therapies through the development process, supporting larger Phase III trials and commercial launches will be a challenge
      Ryan Carpentier, Executive Director of Business Development, Cryoport 09.23.19

    • Biologics, Proteins, Vaccines | Cold Chain Management | Drug Development | Supply Chain
      CAR T for Large Tumors: The Next Frontier?

      CAR T for Large Tumors: The Next Frontier?

      Ryan Carpentier of Cryoport discusses the successes and the challenges these exciting new therapies present
      Ryan Carpentier, Executive Director of Business Development at Cryoport 09.10.19


    • Biologics, Proteins, Vaccines | cGMP Manufacture | Drug Development | GMPs/GCPs | Regulatory Affairs
      Knowledge Sharing in the Development and Delivery of Biologics

      Knowledge Sharing in the Development and Delivery of Biologics

      The increasing importance of sharing information to build awareness and better manage the complexities of drug development
      Fran L. DeGrazio, Vice President, Scientific Affairs & Technical Services, West Pharmaceutical Services, Inc. 07.15.19

    • Biologics, Proteins, Vaccines | Drug Development
      The Missing Piece in Rare-Disease Drug Development

      The Missing Piece in Rare-Disease Drug Development

      More genetics expertise is crucial in getting these drugs to market.
      Jill Johnston, President, Site Activation Solutions, WCG Clinical Services and Karmen Trzupek, Director, Ocular & Rare Disease Genetics Services, InformedDNA 08.22.18

    • Biologics, Proteins, Vaccines
      Technological Arms Race Could Improve Bio Process Mfg. Efficiency

      Technological Arms Race Could Improve Bio Process Mfg. Efficiency

      Experts warn bio industry needs to do more to create a sustainable pipeline of talent
      06.29.18

    Trending
    • Franco Negron Named CEO Of ApiJect Systems America
    • Obituary Notice: Russell “Russ” Haines
    • Resilience Acquires Ology Bioservices
    • Johnson & Johnson 1Q Results
    • RDIF, Hualan Ink COVID-19 Vaccine Deal
    Breaking News
    • Nanoform, Aprecia Partner to Advance 3DP Nanomedicines
    • KemPharm Receives $10M Milestone for FDA Approval of Azstarys
    • Valneva Focuses on Bilateral Discussions to Supply COVID-19 Vax
    • Syneos, Medable Partner for New Decentralized Capabilities
    • CSafe Global Appoints SVP of Technology and Innovation
    View Breaking News >
    CURRENT ISSUE

    April 2021

    • Small Innovators & Niche CROs
    • Focus on Science
    • Rapid and Data Rich Chromatographic Method Development
    • Preparing Your Post Pandemic Talent Strategy
    • How Modern Near-Infrared Came to Be
    • Securing Your API Supply Chain: Three Keys to Success
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Ashland Supports the Nature Conservancy Forest Restoration Effort to Help Plant a Billion Trees
    Martin Bauer Announces Installation of Agile Filling System at Bethlehem, PA Facility
    PepsiCo and Ingredion Begin Pilot Partnership with Soil and Water Outcomes Fund
    Coatings World

    Latest Breaking News From Coatings World

    AkzoNobel Shareholders Approve Final Dividend at Annual General Meeting
    PPG Maintains EcoVadis Gold Rating
    Sustainable Plastics Will Make Up More Than 15% of Production by 2030
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Getinge Receives FDA Clearance for Multiple Products
    Study Shows Benefits of CCHD Screening Using Masimo SET Pulse Oximetry
    TEAM Technologies Acquires ViruDefense
    Contract Pharma

    Latest Breaking News From Contract Pharma

    RDIF, Minapharm to Make Over 40M Doses of the Sputnik V Vaccine in Egypt
    Bora Pharmaceuticals Completes Health Canada Inspection
    Nanoform, Aprecia Partner to Advance 3DP Nanomedicines
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Knoll Printing & Packaging Commits to a Healthy Ocean and Planet
    New Sustainable Jar from APC Packaging
    Qosmedix Launches Corporate Social Responsibility Initiative
    Happi

    Latest Breaking News From Happi

    Multi-Purpose Sustainable 'Just Add Water' Household Cleaner Expands Cleaning Products
    Kao Launches Oribe in Japan
    Love Beauty and Planet Shares Sustainability Initiatives With Refillable Hair Care at Target
    Ink World

    Latest Breaking News From Ink World

    Kumon North America Adds Speedmaster XL 106 from Heidelberg
    Acrylic Resins Market Worth $21.9 Billion by 2025: MarketsandMarkets
    SE-DA Invests in Kornit Presto S
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Epson upgrades SurePress demo facility
    Xeikon helps converters navigate toner and inkjet
    Mactac introduces Simply Sustainable initiative
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Savaré Strengthens Technical Support for the Americas
    FiberVisions, Avgol Partner with Polymateria
    High-Tech Conversions Launches Wipes Dispenser
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    FDA Clears Orthofix's 3D-Printed FORZA Titanium TLIF Spacer System
    Patients Conclude Clinical Visits in Knee Osteoarthritis Treatment Study
    SeaSpine Begins Limited Rollout of WaveForm TO 3D-Printed Interbodies
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Identiv, Ameta International Announce US, Canadian Distribution Partnership
    Adesis Achieves ISO 9001:2015 Certification
    Louis Widmer SA Complies with EU Anti-Counterfeiting Directive with Zebra Technologies’ Solution

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login